Patients with an aggressive brain cancer who received a COVID-19 vaccine in the months before tumor surgery lived roughly twice as long as unvaccinated patients, according to an analysis that has not yet been peer-reviewed.
The preprint, posted to medRxiv in July by researchers at the University of Alabama at Birmingham, examined 187 people with glioblastoma who had tumors biopsied or surgically removed between 2022 and 2025.
